Enrolling: NIH Intramural Study

Share on facebook
Share on twitter
Share on email
Overview

The objective of this research study is to look in-depth at the clinical and biological characteristics of ME/CFS. Participants with ME/CFS are inpatients at the clinical center at NIH for approximately two weeks on their first visit and another two weeks if they return for the second round of the study.

There will be a total of 40 people with ME/CFS, 40 healthy controls, and 20 people with successfully treated Lyme disease in the study. The study is open to international participants.


Participants must meet the following qualifications:
– Sudden onset after an infection
– Meet the Canadian Consensus Criteria and Fukuda Criteria
– Be between the ages of 18 and 60
– Severe symptoms that started between six months and five years ago
– Be able to participate in all of the tests listed at https://mecfs.ctss.nih.gov/, including a one-day exercise test


Who:

The study is run out of the Clinical Center at NIH by Dr Nath, intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health. Scientists at NIH from ten institutes are working on different aspects of the protocol.


When:

Ongoing


How to Participate:

Email: [email protected] or [email protected]
Call: 301-496-1788


What:

The study looks at a wide range of symptoms and potential co-existing disorders including POTS, PEM, cognitive problems, potential mitochondrial issues, and muscle disorders. There are also studies into genetics and gene expression. The study website at https://mecfs.ctss.nih.gov/ includes details on tests that will be done throughout the study.

After your first visit, an adjudication panel of expert clinicians will review your case, including written notes and test results, and confirm that you meet the Canadian Consensus Criteria and Fukuda Criteria and don’t have any disqualifying co-existing conditions. If all of the clinicians believe that you meet the relevant criteria, then you will be invited back for a second visit that will include more tests.
The expert clinicians are:

  • Anthony Komaroff
  • Daniel Peterson
  • Lucinda Bateman
  • Andreas Kogelnik
  • Benjamin Natelson

Dr Nath is also on the review panel.

NBC News did an article on the study at https://www.nbcnews.com/health/health-news/nih-study-takes-deepest-dive-yet-baffling-condition-n754271


Where:

NIH Clinical Center, Bethesda, MD, USA


Compensation:

NIH will cover the cost of a flight from anywhere in the US for US participants and a caretaker, along with providing a hotel room for the caretaker. International participants are welcome but will have to arrange their own travel to NIH in Bethesda, MD.

You will receive $560 for completing the first visit and an additional $50 for completing cytapheresis. You will receive $1015 for completing the second visit, including the exercise test. You will receive an additional $100 for getting an optional skin biopsy done and $250 for getting an optional muscle biopsy done.

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Choose your top ten ME/CFS research priorities – UK survey launched

Take the survey The ME/CFS Priority Setting Partnership (PSP) is giving you the opportunity to define your top ten priorities for future ME/CFS research. In partnership with the James Lind Alliance, the ME/CFS Priority Setting Partnership is launching their second survey today. The research questions in this survey are based on over 5300 ideas submitted

Read More »

Statement from Forward-ME on NICE Roundtable

After NICE held its roundtable to discuss the new ME/CFS guideline, Forward-ME (which #MEAction UK is a member of) have produced the below statement. Clinician and Patient Support Confirmed for new NICE Guideline on ME/CFS. On Monday, Forward-ME and member charities attended a roundtable to review the new ‘NICE guideline on ME/CFS’ with representatives from

Read More »

Is NIH blowing another opportunity to advance ME/CFS research?

Be sure to attend the telebriefing by the Trans-NIH ME/CFS Working Group this Friday (10/22) at 3PM ET. The National Institutes of Health (NIH) has many questions to answer about its lack of tangible progress or strategic acceleration of medical research for people with ME. Read Our Questions for NIH ME/CFS research opportunity being missed

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top